Free Trial
NASDAQ:IDXX

IDEXX Laboratories Q3 2025 Earnings Report

IDEXX Laboratories logo
$633.84 +13.73 (+2.21%)
Closing price 10/2/2025 04:00 PM Eastern
Extended Trading
$633.26 -0.58 (-0.09%)
As of 10/2/2025 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IDEXX Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
$3.14
Beat/Miss
N/A
One Year Ago EPS
N/A

IDEXX Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.07 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

IDEXX Laboratories Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, October 30, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

IDEXX Laboratories Earnings Headlines

Idexx Laboratories initiated with a Neutral at UBS
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More IDEXX Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IDEXX Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IDEXX Laboratories and other key companies, straight to your email.

About IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) is a global leader in the development, manufacturing and distribution of diagnostic and information technology solutions for animal health, water testing and dairy markets. The company’s core business activities center on providing veterinarians and farmers with rapid, accurate diagnostic tools and services to improve animal care and productivity. IDEXX’s offerings span in-clinic diagnostic systems, reference laboratory testing, and software solutions that streamline practice management and enhance decision-making.

The company’s product portfolio includes immunoassay analyzers, hematology instruments, chemistry systems and consumables designed for use in companion animal and livestock settings. Point‐of‐care tests for infectious diseases, endocrine disorders and more enable veterinarians to receive results during patient visits. IDEXX Reference Laboratories complement in-clinic diagnostics with advanced testing services covering genetics, pathology and microbiology. In addition, IDEXX offers digital imaging, telehealth and practice management software to optimize workflow and support clinical excellence.

Founded in 1983 and headquartered in Westbrook, Maine, IDEXX has grown into a multinational enterprise serving customers in more than 175 countries. The company maintains a network of regional offices, manufacturing facilities and reference labs across North America, Europe, Asia-Pacific, Latin America and emerging markets. IDEXX’s global footprint is supported by ongoing investment in research and development, aimed at expanding diagnostic capabilities and enhancing connectivity across veterinary practices.

Under the leadership of Chairman, President and Chief Executive Officer Jonathan W. Ayers, IDEXX continues to pursue innovation in animal health diagnostics and data-driven practice management. The company’s emphasis on science-driven solutions and customer support has established it as a trusted partner for veterinarians, livestock producers and water quality experts worldwide.

View IDEXX Laboratories Profile

More Earnings Resources from MarketBeat